Watch as the Professor buys a bike for Penny to show how the broken health care payment system hurts Medicare patients. They explore that by creating a support program based on income, we can help Medicare patients buy private insurance instead of being stuck with poor government care. READ THE STUDY https://www.youtube.com/watch?v=rvlwyvVGcNY...
Watch as Penny is unhappy that she has to enter the geography bee instead of the science fair due to bureaucratic rules at school. The Professor explores how, much in the same way, eliminating unnecessary barriers can produce a more efficient and productive health care system. To learn more, read the Coverage Denied series at www.medecon.org https://www.youtube.com/watch?v=RmLoJWQ935M...
Watch Dr. Wayne Winegarden, Director of PRI's Center for Medical Economics and Innovation, respond to news that the federal government will stop paying for COVID-19 vaccines on NTD Business. https://youtu.be/f6gCvoK_Pv4?t=324...
Watch Dr. Wayne Winegarden, director of PRI's Center for Medical Economics and Innovation, discuss how the price control provisions in the so-called Inflation Reduction Act of 2022 will negatively impact innovation in an interview on NTD Business. https://www.youtube.com/watch?v=IhcUIKbt-_Y&t=467s...
Watch PRI’s Wayne Winegarden, director of our Center for Medical Economics and Innovation, discuss efforts by the Federal Trade Commission to considering ordering large pharmacy benefits managers to study the competitive impact of contractual provisions, reimbursement adjustments, and other practices affecting drug prices on Scripps National News. https://youtu.be/DQsjKM44ScQ...
Listen to Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, discuss his recent 340B hospital study on AM 1590, KWBG Radio in Boone, IA. [audio mp3="https://medecon.org/wp-content/uploads/2022/02/Wayne-Winegarden-PRI-340B-Study-012522.mp3"][/audio]...
Watch Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, discuss how the Biden plan to lower prescription drug costs is disappointing and would lead to less access and higher costs for patients with Scripps National News. https://youtu.be/IeokdBjtjqk...
Listen to PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy Sally C. Pipes provide insight on how the full approval Pfizer-BioNTech Covid-19 vaccine might increase vaccinations and affect vaccine mandates on Real News with Rick Outzen on WCOA-AM in Pensacola, FL. ...
Watch Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, discuss his recent study showing how a two-part drug pricing system would ensure prices more accurately reflect how patients value drugs with Scripps National News. The report aired on 60 television stations in 42 markets across the country reaching 31% of U.S. TV households. https://youtu.be/AK1CIGa-w5c...
The Pioneer Institute and Pacific Research Institute hosted an educational webinar on the importance of protecting treatment access, innovation, and equity as Washington addresses drug pricing reforms on July 19, 2021. Pioneer Institute, PRI, and special guests explored the current policy landscape on treatment value and access and how policy proposals that lean on the Institute for Clinical and Economic Review, or ICER, and similar approaches could impact certain patients. William “Bill” Smith, PhD, Visiting Fellow in Life Sciences, Pioneer...
Dr. Henry Miller, PRI senior fellow in health care studies, joins PRI's "Next Round" podcast with an update on the pandemic, the progress of vaccine distribution, and his perspective on the CDC’s pause on the use of the Johnson & Johnson vaccine. https://youtu.be/sMwlbxAjrNE...
Watch PRI's Dr. Wayne Winegarden discuss the importance of improving competitions for biosimilars to increase access to these high value medications for more patients on two "Bending the Cost Curve" panel discussions hosted by State of Reform. https://youtu.be/oJTD34j-E-Y https://youtu.be/hu8sWIn3u_A...
Listen to PRI's Dr. Wayne Winegarden discuss the importance of increasing health care transparency and his recent Inside Sources op-ed with host Steve Noxon on "Talk of the Town" on WATR Radio in Waterbury, CT. Click here to listen to the interview...
As they approach the end of the Drug Pricing Maze, the Professor and Pete explore reforms to fix a broken system and encourage the use of cheaper biosimilars that can help patients and the health care system save big. They also learn what can be done to make very expensive gene therapies that provide a lot of value for patients more affordable and accessible....
Dr. Henry Miller, PRI senior fellow in health care studies and former founding director of the FDA’s Office of Biotechnology, joins PRI's "Next Round" podcast with an update on efforts to develop vaccines and therapeutics to fight Covid-19. He discusses how a transition between two presidential administrations will affect the work of the federal government in fighting Covid-19, whether a national mask mandate is a good idea, whether Governors like Gavin Newsom should initiate state-level reviews of potential vaccines, and...
If you’ve ever had a medical procedure and received a large bill from your hospital because, unknown to you, one of your doctors was not in your insurance network – that’s the subject of this podcast. On "Next Round," PRI senior fellow Wayne Winegarden discusses his recently released study on “Surprise Medical Billing.” He explains how it happens, why it happens, and the reforms that could prevent it. https://youtu.be/G4BvoVHT4so...
As they approach the end of the Drug Pricing Maze, the Professor and Pete explore reforms to fix a broken system and encourage the use of cheaper biosimilars that can help patients and the health care system save big. They also learn what can be done to make very expensive gene therapies that provide a lot of value for patients more affordable and accessible....
The Professor and Pete must collect 3 keys to finally escape the drug pricing maze. The first key involves reforms to increase drug affordability for patients who buy their drugs at a pharmacy. The Professor shows Pete that these reforms should ensure that prices are transparent, easy to understand, and help patients benefit from the large discounts that are being paid....
The Professor explains to Pete that some of the claims that he’s heard on TV about drug price controls are just spin. He shows Pete that whatever name you call them, drug price controls will reduce innovation and threaten people’s access to life-saving medicines....